13F filer · CIK 1503556
MV Management XI, L.L.C.
Menlo Park, CA · filing since Q4 2021 · last filing Nov 14, 2023
Reported value
$60.1M
+$3.0M vs prior
Positions
3
New / sold out
0 / 0
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $9.1M
Top-10 weight
100.0%
Biggest buys vs Q2 2023
No new or increased positions this quarter.
Biggest sells vs Q2 2023
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | RECURSION PHARMACEUTICALS IN | -1,183,146 | -60.0% | $-9.1M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2023
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ROVER GROUP INCCOM CL A | 8,638,513 | $54.1M | 89.96% |
| 2 | RECURSION PHARMACEUTICALS INCL A | 788,762 | $6.0M | 10.04% |
| 3 | ANGI INCCOM CL A NEW | 1,898 | $3.8K | 0.01% |